Kent Durbin

Chief Financial Officer

Douglas Pharmaceuticals

Kent has been with Douglas for fourteen years, the last five as CFO during which time the business doubled turnover to $250MM and expanded operations in Australia, Fiji and the USA. Originally training as a CA with EY in Auckland, Kent transferred to EY in the UK working in corporate finance, before joining a startup London restructuring firm. Kent is passionate about healthcare and is excited about transformative solutions coming out of Douglas as it invests over $100MM in the coming fiscal.